Anzeige
Mehr »
Donnerstag, 18.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
377 Leser
Artikel bewerten:
(1)

YourBio Health, Inc.: Stephen Hahn, M.D., former U.S. FDA Commissioner, joins YourBio Health as interim Chief Medical Officer

BOSTON, Sept. 9, 2021 /PRNewswire/ -- YourBio Health, Inc., developers of the world's first painless push-button blood collection device, announced today that Stephen Hahn, M.D. joins as interim Chief Medical Officer; he also serves as the Chief Medical Officer, for the Preemptive Medicine and Health Security initiative at Flagship Pioneering at-large. Dr. Hahn previously served as the U.S. Food and Drug Administration Commissioner from 2019-2021.

Prior to joining the FDA, he served as Chief Medical Executive at the world-renowned MD Anderson Cancer Center in Houston. In 2017, he was named Deputy President and Chief Operating Officer and was responsible for the day-to-day operations of the Cancer Center. Prior to MD Anderson, Dr. Hahn served as head of the radiation oncology department at the University of Pennsylvania's Perelman School of Medicine. During his time as an active clinician, Hahn specialized in treating thoracic, sarcoma, and genitourinary cancers, as well as the use of photodynamic therapy for the treatment of pre-invasive and invasive malignancies. Hahn remains Board Certified in Internal Medicine, Medical Oncology, and Radiation Oncology.

During his time as the 24th Commissioner of the U.S. Food and Drug Administration, Dr. Hahn led the 17,000+ person agency that regulates approximately 20 percent of consumer spending in the United States. He oversaw both COVID and non-COVID regulatory affairs, including therapeutics and vaccine development, devices, diagnostics, and clinical trials.

"We welcome Stephen Hahn M.D. as interim Chief Medical Officer," said Harry Wilcox, Executive Chairman of YourBio Health. "Steve brings with him two decades of distinguished leadership in healthcare strategy, clinical experience, and commercialization know-how. His invaluable and extensive experience will help us achieve our aspirations and future growth."

About YourBio Health

YourBio Health puts health information in the hands of the individual. As a direct-to-consumer brand that believes knowledge is power, we will offer convenient at-home testing so individuals can easily monitor their personal health information and make informed decisions about their lives. Backed by the latest science, technology, and certified central laboratories to guarantee best-in-class test results, the company's goal is to enable people to feel safe, confident, educated, and in control of their short and long-term health.

YourBio Health was founded by Flagship Pioneering, which conceives, creates, resources, and develops first-in-category bioplatform companies to transform human health and sustainability. Since its launch in 2000, the firm has, through its Flagship Labs unit, applied its unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $130 billion in aggregate value.

www.yourbiohealth.com

© 2021 PR Newswire
Solarbranche vor dem Mega-Comeback?
Lange galten Solaraktien als Liebling der Börse, dann kam der herbe Absturz: Zinsschock, Überkapazitäten aus China und ein Preisverfall, der selbst Marktführer wie SMA Solar, Enphase Energy oder SolarEdge massiv unter Druck setzte. Viele Anleger haben der Branche längst den Rücken gekehrt.

Doch genau das könnte jetzt die Chance sein!
Die Kombination aus KI-Explosion und Energiewende bringt die Branche zurück ins Rampenlicht:
  • Rechenzentren verschlingen Megawatt – Solarstrom bietet den günstigsten Preis je Kilowattstunde
  • Moderne Module liefern Wirkungsgrade wie Atomkraftwerke
  • hina bremst Preisdumping & pusht massiv den Ausbau
Gleichzeitig locken viele Solar-Aktien mit historischen Tiefstständen und massiven Short-Quoten, ein perfekter Nährboden für Kursrebound und Squeeze-Rally.

In unserem exklusiven Gratis-Report zeigen wir dir, welche 4 Solar-Aktien besonders vom Comeback profitieren dürften und warum jetzt der perfekte Zeitpunkt für einen Einstieg sein könnte.

Laden Sie jetzt den Spezialreport kostenlos herunter, bevor die Erholung am Markt beginnt!

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.